Literature DB >> 28509222

Fabry's disease discovered with chance urinary mulberry cells: a case report.

Takashi Nakamichi1, Mariko Miyazaki2, Keisuke Nakayama1, Mitsuhiro Sato3, Naoki Akiu4, Toshinobu Sato3, Hiroshi Sato1, Sadayoshi Ito1.   

Abstract

Fabry's disease (FD) is a rare X-linked lysosomal storage disorder. Novel enzyme replacement therapy (ERT) at an early stage can slow the progression of cardiovascular and renal dysfunction. Urinary mulberry cells are occasionally found in renal FD. We report a case of variant FD in which detection of urinary mulberry cells led to an early diagnosis. A 36-year-old Japanese man was referred to our hospital because mulberry cells had been detected during urinalysis. Proteinuria and renal dysfunction were not observed. His plasma alpha-galactosidase activity was very low. Renal biopsy revealed typical foamy changes in the glomerular podocytes and tubular epithelial cells that are found in renal FD. Based on the detection of urinary mulberry cells, we successfully started ERT before the patient's renal function deteriorated. Clinical nephrologists and laboratory technicians should recognize the importance of screening for mulberry cells during urinalysis as this is a simple, inexpensive, and non-invasive method for diagnosing FD.

Entities:  

Keywords:  Enzyme replacement therapy; Fabry’s disease; Mulberry cell

Year:  2012        PMID: 28509222      PMCID: PMC5413727          DOI: 10.1007/s13730-012-0038-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  14 in total

1.  Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

Authors:  C M Eng; N Guffon; W R Wilcox; D P Germain; P Lee; S Waldek; L Caplan; G E Linthorst; R J Desnick
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Significance of screening for Fabry disease among male dialysis patients.

Authors:  Mayuri Ichinose; Masaaki Nakayama; Toya Ohashi; Yasunori Utsunomiya; Masahisa Kobayashi; Yoshikatsu Eto
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

3.  Renal pathologic lesions and functional alterations in a man with Fabry's disease.

Authors:  R C Pabico; B C Atancio; B A McKenna; T Pamukcoglu; R Yodaiken
Journal:  Am J Med       Date:  1973-09       Impact factor: 4.965

4.  Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.

Authors:  Christoph Wanner; João P Oliveira; Alberto Ortiz; Michael Mauer; Dominique P Germain; Gabor E Linthorst; Andreas L Serra; László Maródi; Renzo Mignani; Bruno Cianciaruso; Bojan Vujkovac; Roberta Lemay; Dana Beitner-Johnson; Stephen Waldek; David G Warnock
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

5.  Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.

Authors:  M Tanaka; T Ohashi; M Kobayashi; Y Eto; N Miyamura; K Nishida; E Araki; K Itoh; K Matsushita; M Hara; K Kuwahara; T Nakano; N Yasumoto; H Nonoguchi; K Tomita
Journal:  Clin Nephrol       Date:  2005-10       Impact factor: 0.975

Review 6.  Cardiovascular manifestations of Fabry disease and the novel therapeutic strategies.

Authors:  Yoshihiko Seino; Hiroshi Takahashi; Hiroko Fukumoto; Kouichi Utsumi; Yukihiko Hirai
Journal:  J Nippon Med Sch       Date:  2005-10       Impact factor: 0.920

7.  An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

Authors:  S Nakao; T Takenaka; M Maeda; C Kodama; A Tanaka; M Tahara; A Yoshida; M Kuriyama; H Hayashibe; H Sakuraba
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

8.  Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data.

Authors:  A Mehta; M Beck; P Elliott; R Giugliani; A Linhart; G Sunder-Plassmann; R Schiffmann; F Barbey; M Ries; J T R Clarke
Journal:  Lancet       Date:  2009-12-12       Impact factor: 79.321

Review 9.  Fabry's disease.

Authors:  Yuri A Zarate; Robert J Hopkin
Journal:  Lancet       Date:  2008-10-18       Impact factor: 79.321

10.  Prevalence of lysosomal storage disorders.

Authors:  P J Meikle; J J Hopwood; A E Clague; W F Carey
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

View more
  8 in total

1.  Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease.

Authors:  Homare Shimohata; Hiroshi Maruyama; Yasunori Miyamoto; Mamiko Takayasu; Kouichi Hirayama; Masaki Kobayashi
Journal:  CEN Case Rep       Date:  2017-06-07

Review 2.  Fabry disease-what cardiologists can learn from the nephrologist: a narrative review.

Authors:  Christine E Kurschat
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

3.  Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.

Authors:  Homare Shimohata; Marina Yamashita; Kentaro Ohgi; Hiroshi Maruyama; Mamiko Takayasu; Kouichi Hirayama; Masaki Kobayashi
Journal:  CEN Case Rep       Date:  2020-03-18

Review 4.  Fabry disease and kidney involvement: starting from childhood to understand the future.

Authors:  Roberto Chimenz; Valeria Chirico; Caterina Cuppari; Giorgia Ceravolo; Daniela Concolino; Paolo Monardo; Antonio Lacquaniti
Journal:  Pediatr Nephrol       Date:  2021-04-30       Impact factor: 3.651

5.  Fabry Disease with Pacemaker Implantation as the Initial Event.

Authors:  Yuji Kato; Ayako Ishikawa; Satoshi Aoki; Hiroyuki Sato; Yoshie Ojima; Saeko Kagaya; Tasuku Nagasawa
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

6.  Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy.

Authors:  Tsugumi Fukunaga; Shingo Nakayama; Takuo Hirose; Kishin Muramatsu; Akari Endo; Yuka Miyake; Go Anan; Ikuko Oba-Yabana; Atsuhiro Kanno; Hannah Nakamura; Junichi Tani; Kimitoshi Nakamura; Kazuhiro Sumitomo; Wako Yumura; Katsutoshi Furukawa; Takefumi Mori
Journal:  Case Rep Nephrol Dial       Date:  2021-11-29

7.  Automated urinary sediment detection for Fabry disease using deep-learning algorithms.

Authors:  Hidetaka Uryu; Ohsuke Migita; Minami Ozawa; Chikako Kamijo; Saki Aoto; Kohji Okamura; Fuyuki Hasegawa; Torayuki Okuyama; Motomichi Kosuga; Kenichiro Hata
Journal:  Mol Genet Metab Rep       Date:  2022-09-28

8.  Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease.

Authors:  Yumi Aoyama; Yusuke Ushio; Takashi Yokoyama; Sekiko Taneda; Shiho Makabe; Miki Nishida; Shun Manabe; Masayo Sato; Hiroshi Kataoka; Ken Tsuchiya; Kosaku Nitta; Toshio Mochizuki
Journal:  Intern Med       Date:  2020-04-01       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.